Related Experiment Video
Updated: Aug 5, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Structure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis
Annalisa L E Carli1,2, Joshua M Hardy3,4, Hanadi Hoblos3,4
1Cancer Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
Abstract:
Doublecortin-like kinase 1 (DCLK1) is a functional serine/threonine (S/T)-kinase and a member of the doublecortin family of proteins which are characterized by their ability to bind to microtubules (MTs). DCLK1 is a proposed cancer driver gene, and its upregulation is associated with poor overall survival in several solid cancer types. However, how DCLK1 associates with MTs and how its kinase function contributes to pro-tumorigenic processes is poorly understood. This review builds on structural models to propose not only the specific functions of the domains but also attempts to predict the impact of individual somatic missense mutations on DCLK1 functions. Somatic missense mutations in DCLK1 are most frequently located within the N-terminal MT binding region and likely impact on the ability of DCLK1 to bind to αβ-tubulin and to polymerize and stabilize MTs. Moreover, the MT binding affinity of DCLK1 is negatively regulated by its auto-phosphorylation, and therefore mutations that affect kinase activity are predicted to indirectly alter MT dynamics. The emerging picture portrays DCLK1 as an MT-associated protein whose interactions with tubulin heterodimers and MTs are tightly controlled processes which, when disrupted, may confer pro-tumorigenic properties.
Insights
Doublecortin-like kinase 1 (DCLK1), a cancer-associated kinase, binds microtubules (MTs). Mutations disrupting DCLK1
Area of Science:
- Molecular Biology
- Cancer Biology
- Structural Biology
Background:
- Doublecortin-like kinase 1 (DCLK1) is a serine/threonine kinase involved in microtubule (MT) binding.
- DCLK1 is implicated as a cancer driver gene, with its overexpression correlating with poor survival in solid tumors.
- The precise mechanisms of DCLK1's MT association and its kinase function in cancer remain unclear.
Purpose of the Study:
- To elucidate the structural basis of DCLK1's interaction with microtubules.
- To predict the functional consequences of somatic missense mutations in DCLK1.
- To understand how DCLK1's kinase activity influences MT dynamics and cancer progression.
Main Methods:
- Review of existing structural models of DCLK1.
- Analysis of mutation data to predict functional impacts.
- Integration of kinase activity and MT binding data.
Main Results:
- Somatic mutations frequently occur in DCLK1's N-terminal MT-binding region, potentially impairing tubulin binding and MT stabilization.
- DCLK1's MT binding affinity is negatively regulated by its auto-phosphorylation.
- Mutations affecting kinase activity are predicted to indirectly alter MT dynamics.
Conclusions:
- DCLK1 functions as an MT-associated protein with tightly regulated interactions.
- Disruption of DCLK1-MT interactions through mutations or altered kinase activity may promote tumorigenesis.
- Understanding these mechanisms offers potential therapeutic targets in cancer.
Related Concept Videos
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation

